Journal article
Diagnostic and therapeutic approaches to lung cancer in Canada and their costs
Abstract
Escalating health care costs have made it imperative to evaluate the resources required to diagnose and treat major illnesses in Canadians. For Canadian men, lung cancer is not only the most common malignancy, but also the major cancer killer. As of 1994, lung cancer is expected to overtake breast cancer as the leading cause of cancer deaths in women. This paper presents a detailed description of the methodology used to determine the direct …
Authors
Evans W; Will B; Berthelot J; Wolfson M
Journal
British Journal of Cancer, Vol. 72, No. 5, pp. 1270–1277
Publisher
Springer Nature
Publication Date
November 1995
DOI
10.1038/bjc.1995.499
ISSN
0007-0920
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AlgorithmsBronchoscopyCanadaCarcinoma, Non-Small-Cell LungCarcinoma, Small CellChemotherapy, AdjuvantCombined Modality TherapyCost ControlDiagnostic ImagingFemaleHealth Care CostsHumansLung NeoplasmsMaleModels, TheoreticalNational Health ProgramsNeoplasm MetastasisNeoplasm Recurrence, LocalNeoplasm StagingPneumonectomyRadiotherapy